Don't be surprised if Incannex's pivot to the USA Investor Audience comes into focus in the coming days/weeks.
>> A huge company milestone is inbound IMO
Filing an IND with the FDA in the USA for our IHL-42X Phase 2 / 3 Trials, based in the USA.
This will be IHL's first FDA-monitored and USA-based Phase 2/ 3 Trials.
>> Re-directing our Incannex Website Domain from .com.au to now .com only, maybe in preparation for a new USA audience too!
Good luck to all holders
Don't be surprised if Incannex's pivot to the USA Investor...
-
- There are more pages in this discussion • 407 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)